The results showed no significant difference in TLR2 expression on MDSC subsets, whereas TLR4 was upregulated in malignant ovarian tumors, particularly on PMN-MDSCs (Fig. 5A-D). The gene discussed is TLR4; the disease is ovarian cancer.